BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8463169)

  • 21. BRO beta-lactamase alleles, antibiotic resistance and a test of the BRO-1 selective replacement hypothesis in Moraxella catarrhalis.
    Levy F; Walker ES
    J Antimicrob Chemother; 2004 Feb; 53(2):371-4. PubMed ID: 14729761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. bro {beta}-lactamase and antibiotic resistances in a global cross-sectional study of Moraxella catarrhalis from children and adults.
    Khan MA; Northwood JB; Levy F; Verhaegh SJ; Farrell DJ; Van Belkum A; Hays JP
    J Antimicrob Chemother; 2010 Jan; 65(1):91-7. PubMed ID: 19889789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the plasmid-mediated beta-lactamase in Branhamella catarrhalis, with special reference to substrate affinity.
    Eliasson I; Kamme C
    J Antimicrob Chemother; 1985 Feb; 15(2):139-49. PubMed ID: 3872294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recognition of a new Branhamella catarrhalis beta-lactamase--BRO-3.
    Christensen JJ; Keiding J; Schumacher H; Bruun B
    J Antimicrob Chemother; 1991 Nov; 28(5):774-5. PubMed ID: 1778881
    [No Abstract]   [Full Text] [Related]  

  • 25. Antimicrobial susceptibility to β-lactam antibiotics and production of BRO β-lactamase in clinical isolates of Moraxella catarrhalis from a Japanese hospital.
    Yamada K; Arai K; Saito R
    J Microbiol Immunol Infect; 2017 Jun; 50(3):386-389. PubMed ID: 28057435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-lactamase production in the upper respiratory tract flora.
    Eliasson I; Kamme C; Prellner K
    Eur J Clin Microbiol; 1986 Oct; 5(5):507-12. PubMed ID: 3490974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Moraxella (Branhamella) catarrhalis BRO beta-lactamase: a lipoprotein of gram-positive origin?
    Bootsma HJ; Aerts PC; Posthuma G; Harmsen T; Verhoef J; van Dijk H; Mooi FR
    J Bacteriol; 1999 Aug; 181(16):5090-3. PubMed ID: 10438784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis?
    Pottumarthy S; Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Nov; 53(3):225-31. PubMed ID: 16257168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contemporary prevalence of BRO beta-lactamases in Moraxella catarrhalis: report from the SENTRY antimicrobial surveillance program (North America, 1997 to 2004).
    Deshpande LM; Sader HS; Fritsche TR; Jones RN
    J Clin Microbiol; 2006 Oct; 44(10):3775-7. PubMed ID: 17021108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrageneric and intergeneric transfer of Branhamella catarrhalis beta-lactamase production.
    Kamme C; Wang M; Ståhl S
    Scand J Infect Dis; 1984; 16(2):153-5. PubMed ID: 6610925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic susceptibilities and drug resistance in Moraxella (Branhamella) catarrhalis.
    Wallace RJ; Nash DR; Steingrube VA
    Am J Med; 1990 May; 88(5A):46S-50S. PubMed ID: 2111092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extraction of beta-lactamase from Moraxella catarrhalis.
    Fung CP; Yeo SF; Livermore DM
    J Antimicrob Chemother; 1994 Jul; 34(1):183-4. PubMed ID: 7961208
    [No Abstract]   [Full Text] [Related]  

  • 33. Classification of beta-lactamases from Branhamella catarrhalis in relation to penicillinases produced by other bacterial species.
    Labia R; Barthelemy M; Le Bouguennec CB; Buu Hoi-Dang Van A
    Drugs; 1986; 31 Suppl 3():40-7. PubMed ID: 3488196
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Raveendran S; Kumar G; Sivanandan RN; Dias M
    Int J Microbiol; 2020; 2020():7316257. PubMed ID: 32089697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of inoculum size on the in-vitro susceptibility to beta-lactam antibiotics of Moraxella catarrhalis isolates of different beta-lactamase types.
    Yeo SF; Livermore DM
    J Med Microbiol; 1994 Apr; 40(4):252-5. PubMed ID: 8151675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outer membrane vesicles shield Moraxella catarrhalis β-lactamase from neutralization by serum IgG.
    Schaar V; Paulsson M; Mörgelin M; Riesbeck K
    J Antimicrob Chemother; 2013 Mar; 68(3):593-600. PubMed ID: 23184710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural insertion of the bro-1 β-lactamase gene into the gatCAB operon affects Moraxella catarrhalis aspartyl-tRNA(Asn) amidotransferase activity.
    Akochy PM; Lapointe J; Roy PH
    Microbiology (Reading); 2012 Sep; 158(Pt 9):2363-2371. PubMed ID: 22745266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moraxella (Branhamella) catarrhalis--clinical and molecular aspects of a rediscovered pathogen.
    Enright MC; McKenzie H
    J Med Microbiol; 1997 May; 46(5):360-71. PubMed ID: 9152030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection, distribution and inhibition of Branhamella catarrhalis beta-lactamases.
    Philippon A; Riou JY; Guibourdenche M; Sotolongo F
    Drugs; 1986; 31 Suppl 3():64-9. PubMed ID: 3015547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upper respiratory tract infections. Ecological and therapeutic aspects of beta-lactamase production with special reference to Branhamella catarrhalis.
    Eliasson I; Kamme C
    Drugs; 1986; 31 Suppl 3():116-21. PubMed ID: 3488190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.